Sign in to view content

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch

Estephania Feria, MD

Video
Published 2019

Related

Abicipar Pegol Phase 3 AMD Studies
Pravin U. Dugel, MD
Updates from the Field
2017
Correlation Of Ganglion Cell Layer Damage And Diabetic Macular Ischemia Using OCT Angiography and Their Relationship With Visual Acuity in Diabetes
Dilraj S Grewal, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Episode 25: RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD with Dr. Mark Gillies
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019

Category: AMD-Neovascular

See more